NOT MEDICAL ADVICE. No information on this site should be considered medical advice. Research peptides are not intended for human consumption — in-vitro lab use only. Consult a physician prior to introducing anything into the human body.

Cognitive, Neuro & Sleep

Nootropics, neuroregenerative, sleep and mood-regulating peptides explored in cognitive and neurological research. 20 profiles

01

BDNF Mimetic Peptides

Generic category of peptides promoted as BDNF mimetics; specific products are not identified in the literature.

Read profile →
02

Blood-Brain Barrier Peptide Analogs

Catalog name implying peptides that cross or act at the blood-brain barrier; no specific products are defined in the literature.

Read profile →
03

Central Pain Pathway Modulator Analogs

Umbrella catalog name implying peptides acting on central pain processing; no specific compounds are documented.

Read profile →
04

Cerebrolysin Peptide Fraction

Pharmaceutical preparation of low-molecular-weight peptides derived from porcine brain, approved in some countries for dementia and stroke recovery.

Read profile →
05

CNTF Analogs

Category of products sold as CNTF-related peptides; CNTF and its clinical analog Axokine are real, but these items are not documented.

Read profile →
06

Conolidine

Monoterpene indole alkaloid from Tabernaemontana divaricata studied as a candidate non-opioid analgesic; a small molecule, not a peptide.

Read profile →
07

Cortagen

Peptide marketed as a brain-related bioregulator; identity and supporting studies could not be confirmed in the literature.

Read profile →
08

Descending Inhibitory Pathway Modulators

Catalog name implying peptides acting on descending inhibitory pain pathways; no specific products are characterized.

Read profile →
09

Dihexa

Synthetic small-molecule compound developed in academic research on HGF/c-Met signaling; reported to improve memory in rodent models. Not a peptide.

Read profile →
10

DL-148 (Mood Peptide Analog)

Vendor designation for a mood peptide analog; no compound with this identifier appears in the literature.

Read profile →
11

DSIP (Delta Sleep-Inducing Peptide)

Nonapeptide first described in the late 1970s as a sleep-promoting factor; human sleep effects have been inconsistent across published studies.

Read profile →
12

Dynorphin Analogs

Catalog category of dynorphin-related peptides; dynorphins are real kappa-opioid peptides, but these products are undocumented.

Read profile →
13

KLOW (Lys-Pro-Val Complex)

Vendor-defined name used inconsistently for KPV or for multi-peptide blends; no peer-reviewed literature on KLOW itself.

Read profile →
14

NGF Analogs

Catalog heading for products claimed to mimic nerve growth factor; NGF is a large protein, and these analogs lack published identity.

Read profile →
15

Noopept

Dipeptide-derived nootropic (N-phenylacetyl-L-prolylglycine ethyl ester) developed in Russia; animal literature with limited human trials.

Read profile →
16

Nootropic Peptide Complex Analogs

Vendor category grouping nootropic peptide products; no fixed composition or published research identity.

Read profile →
17

Pinealon

A synthetic tripeptide from the Russian bioregulatory-peptide program, studied mainly in animal models for neuroprotective and cognitive effects.

Read profile →
18

Selank

A tuftsin-related synthetic heptapeptide developed in Russia as an anxiolytic, studied for anxiety-spectrum and cognitive effects.

Read profile →
19

Semax

A synthetic ACTH(4-10) heptapeptide analog registered in Russia as a nootropic, studied for cognitive and neuroprotective effects.

Read profile →
20

Sensory Integration Peptide Analogs

A vendor category combining sensory integration with peptide analogs; no such research peptide family exists in the literature.

Read profile →